Are ASX growth shares still worth holding in 2022?

ASX growth shares: Will they still be all the rage in 2022?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • ASX growth shares have been in vogue for years now
  • But one expert believes their time in the spotlight may have come and gone
  • Here are some of the bearish arguments and bullish outlooks on ASX growth shares

For many ASX investors, much of their excitement of the stock market comes from picking a winning growth share and (hopefully) watching it do its thing.

But have ASX growth shares had their moment? One expert is going against the grain to declare the time has come to turn away from growth shares and towards more established investments.

Are they right? Here are some arguments for and against investing in growth shares in 2022.

Big red letters on a seesaw spell growth, indicating share price movements for ASX growth shares

Image source: Getty Images

ASX growth shares: the bulls and the bears

Epoch Global Equity Shareholder Yield portfolio manager, John Tobin has come out swinging against growth shares today. He believes they will suffer in a rising interest rates environment.

According to Tobin, growth stocks have been outperforming established shares since 2020 due to a period of "artificially low interest rates".

"Our argument is [growth stocks] are going to face stronger headwinds when rates rise," he said.

"It's about the math, you can't get around it … for a given increase in interest rates, the impact on present value is greater for cash flows in the distant future."

However, other experts counter Tobin's bearish outlook with their own bullish arguments.

Montgomery Investment Management chair and chief investment officer, Roger Montgomery claims the pull-back experienced by the S&P/ASX 200 Index (ASX: XJO) in 2022 has left many growth shares trading for bargain prices.

In a piece published to Livewire, Montgomery said, "the current equity correction has taken a lot of the froth out of the market.

"But caught up in the carnage have been a number of high-quality companies with years of growth ahead."

Among them, are tech shares Megaport Ltd (ASX: MP1) and Pro Medicus Limited (ASX: PME). Each has had their price-to-earnings (P/E) ratios fall between 31% and 33% since the start of 2022, according to the expert.

Meanwhile, those of Transurban Group (ASX: TCL) and Reece Ltd (ASX: REH) have fallen between 25% and 29%.

Montgomery says now is the time to get in on "some of the highest quality names in the market". He continued:

This is … a plain vanilla correction that will see investors who have taken on too much risk in the quest for returns suffer more than those who have been disciplined about quality and value.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended MEGAPORT FPO and Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.
Growth Shares

3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

2 ASX shares tipped to grow at least 50% in the next 12 months

These stocks could be some of the best ones to own today.

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Growth Shares

What's driving the wild swings in Telix shares?

The ASX biotech stock offers high-growth potential, but it comes with volatility.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Growth Shares

3 stellar ASX growth shares to buy now with 30% to 70% upside

Analysts have buy ratings and lofty price targets on these shares.

Read more »

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX shares that I rate as buys today for both growth and dividends!

These businesses have plenty going for them. I’m calling them buys…

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Market News

NextDC shares rocket 27% higher: Buy, hold or sell?

Can NextDC shares keep climbing higher, or have they now peaked?

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs, and scientific symbols as she smiles.
Growth Shares

3 exciting ASX shares you won't want to miss out on

These ASX shares are not just growing. They are expanding into much larger opportunities.

Read more »

A woman standing on the street looks through binoculars.
Growth Shares

Here are the latest growth forecasts for the Wesfarmers share price

Bunnings and Kmart could be unstoppable forces in the years ahead.

Read more »